Serum ghrelin and cholesterol values in suicide attempters

Neuropsychobiology

Volumn 54, Issue 1, 2006, Pages 59-63

  Atmaca, Murad ^a   Tezcan, Ertan ^a   Parmaksiz, Serap ^a   Saribas, Mehtap ^a   Ozler, Sinan ^a   Ustundag, Bilal ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Cholesterol; Ghrelin; Serotonin; Suicide

Indexed keywords

CHOLESTEROL; GHRELIN;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE; SUICIDE ATTEMPT;

ADOLESCENT; ADULT; CHOLESTEROL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PEPTIDE HORMONES; RADIOIMMUNOASSAY; SUICIDE, ATTEMPTED;

EID: 33750683344     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096039     Document Type: Article

References (36)

1. Freedman DS, Byers T, Barrett DH, Stroup NE, Eaker E, Monroe-Blum E: Plasma lipid levels and psychologic characteristics in men. Am J Epidemiol 1987;14:507-517.
2. Golomb BA: Cholesterol and violence: is there a connection? Ann Int Med 1998;128:478-487.
3. Modai I, Valevski A, Kikinzon L, Jerushalmy Z, Weizman A: Lack of association between cholesterol blood levels and platelet serotonin uptake. Eur Psychiatry 1995;10:352-354.
4. Bocchetta A, Chillotti C, Carboni G, Oi A, Ponti M, Del Zompo M: Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatr Scand 2001;104:37-41.
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
6. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K: Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-4758.
7. Mori K, Yoshimoto A, Takaya K, Hosoda K, Ariyasu H, Yahata K, Mukoyama M, Sugawara A, Hosoda H, Kojima M, Kangawa K, Nakao K: Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 2000;486:213-216.
8. Gualillo O, Caminos JE, Blanco M, García-Caballero T, Kojima M, Kangawa K, Dieguez C, Casanueva F: Ghrelin, a novel placental-derived hormone. Endocrinology 2001;142:788-794.
9. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I: Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000;141:4797-4800.
10. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992-5995.
11. Tschöp M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000;407:908-913.
12. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K: Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001;50:227-232.
13. Antonijevic IA, Murck H, Frieboes RM, Horn R, Brabant G, Steiger A: Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiatr Res 1998;32:403-410.
14. Inui A: Feeding and body-weight regulation by hypothalamic neuropeptides - mediation of the actions of leptin. Trends Neurosci 1999;22:62-67.
15. Contarino A, Gold LH: Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior. Neuropeptides 2002;36:103-116.
16. Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HI, Seal LJ, et al: The hypothalamic mechanisms of the hypophysiotropic action ofghrelin. Neuroendocrinology 2002;76:316-324.
17. Friedman JM: Leptin and the regulation of body weight. Harvey Lect 2000;95:107-136.
18. Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Gecici O, Firidin B: Serum leptin and cholesterol values in suicide attempters. Neuropsychobiology2002;45: 124-127.
19. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Interview for DSM-IV Axis I Disorders (SCID-I). New York, New York State Psychiatric Institute, Biometrics Research, 1997.
20. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). American Psychiatric Press, Washington, 1997.
21. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
22. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M: Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001;145:669-673.
23. Alvarez J-C, Cremniter D, Gluck N, Quintin P, Leboyer M, Therond P, Spreux-Varoquaux O: Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res 2000;95:103-108.
24. Alvarez J-C, Creminter D, Lesiuer P, Gregorie A, Gilton A, Macquin-Mavies L, Jarreau C, Spreux-Varoquaux O: Low blood cholesterol and low platelet serotonin levels in violent suicide attempts. Biol Psychiatry 1999;45:1066-1069.
25. Kaplan J, Muldoon M, Manuck S, Mann JJ: Assessing the observed relationship between low cholesterol and violence related mortality: implications for suicide risk. Ann NY Acad Sci 1997;832:57-59.
26. Hawton K, Cowen P, Owens D: Low serum cholesterol and suicide. Br J Psychiatry 1993;162:818-825.
27. Horrobin DF: Phospholipid metabolism and schizophrenia. Schizophr Res 1999;30:105-106.
28. Purnell JQ, Weigle DS, Breen P, Cummings DE: Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 2003;88:5747-5752.
29. Brunetti L, Recinella L, Orlando G, Michelotto B, Di Nisio C, Vacca M: Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol 2002;454:189-192.
30. Roy A, Linnoila M: Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr Scand 1988;78:529-535.
31. Heikkinen M, Aro H, Lönnqvist J: Recent life events and their role in suicide as seen by the spouses. Acta Psychiatr Scand 1992;86:489-494.
32. Josepho SA, Plutchick R: Stress, coping and suicide risk in psychiatric inpatients. Suicide Life Threat Behav 1994;24:48-57.
33. Yehuda R, Southwick SM, Ostroff RB, Mason JW, Giller E Jr: Neuroendocrine aspects of suicidal behavior. Neurol Clin 1988;6:83-102.
34. Taheri S, Lin L, Austin D, Young T, Mignot E: Short Sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:62.
35. Spiegel K, Tasali E, Penev P, Van Cauter E: Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004;141:846-850.
36. Williams DL, Cummings DE: Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr 2005;135:1320-1325.